# Healthstream Inc: filings

HSTM · Nasdaq · CIK 1095565 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hstm.md) · [Financials](/companies/hstm/financials.md) · [Filings](/companies/hstm/filings.md) · [Insiders](/companies/hstm/insiders.md)

## Reports and events: 265 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 913, 8-K 169, 10-Q 53, SC 13G/A 40, 10-K 18, DEF 14A 18, 3 15, DEFA14A 15, 144 10, UPLOAD 10, ARS 9, SC 13G 9, 4/A 8, CORRESP 8, 5 7, EFFECT 6, 8-K/A 5, SCHEDULE 13G/A 5, 424B5 4, POS AM 3, S-3 3, S-8 3, D 2, S-3ASR 2, 10-K/A 1, 144/A 1, S-8 POS 1, SCHEDULE 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 16:15 ET | [8-K](/filings/0001437749-26-031062.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-031062 |
| 2026-09-21 | 16:55 ET | [SCHEDULE 13D](/filings/0002152025-26-000004.md) | Ownership report, active investor | 0002152025-26-000004 |
| 2026-09-15 | 09:27 ET | [8-K](/filings/0001437749-26-030399.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-030399 |
| 2026-09-14 | 09:21 ET | [8-K](/filings/0001437749-26-030240.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-26-030240 |
| 2026-08-06 | 16:31 ET | [10-Q](/filings/0001437749-26-026301.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026301 |
| 2026-08-03 | 16:34 ET | [8-K](/filings/0001437749-26-025455.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-025455 |
| 2026-07-29 | 16:30 ET | [8-K](/filings/0001437749-26-024890.md) | 8.01 Other events | 0001437749-26-024890 |
| 2026-05-29 | 16:34 ET | [8-K](/filings/0001437749-26-018888.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-018888 |
| 2026-05-08 | 17:19 ET | [8-K](/filings/0001437749-26-015956.md) | 5.02 Departure or appointment of officers or directors | 0001437749-26-015956 |
| 2026-05-06 | 16:32 ET | [10-Q](/filings/0001437749-26-015213.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015213 |
| 2026-05-04 | 16:35 ET | [8-K](/filings/0001437749-26-014670.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-014670 |
| 2026-04-10 | 16:05 ET | [DEF 14A](/filings/0001437749-26-012017.md) | Proxy statement, period 2026-05-28 | 0001437749-26-012017 |
| 2026-03-13 | 16:12 ET | [8-K](/filings/0001437749-26-008226.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-008226 |
| 2026-02-27 | 17:33 ET | [10-K](/filings/0001437749-26-005916.md) | Annual report, period 2025-12-31 | 0001437749-26-005916 |
| 2026-02-23 | 16:35 ET | [8-K](/filings/0001437749-26-005117.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-005117 |
| 2025-12-15 | 16:34 ET | [8-K](/filings/0001437749-25-037858.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-037858 |
| 2025-12-09 | 17:10 ET | [8-K](/filings/0001437749-25-037279.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-037279 |
| 2025-11-12 | 09:01 ET | [8-K](/filings/0001437749-25-034261.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-034261 |
| 2025-11-06 | 16:40 ET | [10-Q](/filings/0001437749-25-033632.md) | Quarterly report, period 2025-09-30 | 0001437749-25-033632 |
| 2025-11-03 | 16:36 ET | [8-K](/filings/0001437749-25-032791.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-032791 |
| 2025-10-09 | 21:57 ET | [8-K](/filings/0001437749-25-030734.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-030734 |
| 2025-08-07 | 16:39 ET | [10-Q](/filings/0001437749-25-025468.md) | Quarterly report, period 2025-06-30 | 0001437749-25-025468 |
| 2025-08-04 | 16:34 ET | [8-K](/filings/0001437749-25-024629.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-024629 |
| 2025-05-30 | 16:31 ET | [8-K](/filings/0001437749-25-019005.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-019005 |
| 2025-05-09 | 16:35 ET | [10-Q](/filings/0001437749-25-015812.md) | Quarterly report, period 2025-03-31 | 0001437749-25-015812 |
| 2025-05-08 | 16:40 ET | [8-K](/filings/0001437749-25-015532.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-015532 |
| 2025-05-05 | 16:55 ET | [8-K](/filings/0001437749-25-014567.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-014567 |
| 2025-04-10 | 16:34 ET | [DEF 14A](/filings/0001437749-25-011677.md) | Proxy statement, period 2025-05-29 | 0001437749-25-011677 |
| 2025-03-28 | 16:43 ET | [8-K](/filings/0001437749-25-009903.md) | 5.02 Departure or appointment of officers or directors | 0001437749-25-009903 |
| 2025-03-14 | 18:08 ET | [8-K](/filings/0001437749-25-007571.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-25-007571 |
| 2025-03-11 | 09:29 ET | [8-K](/filings/0001437749-25-006918.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-006918 |
| 2025-02-28 | 16:06 ET | [8-K](/filings/0001437749-25-005710.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-005710 |
| 2025-02-28 | 16:05 ET | [10-K](/filings/0001437749-25-005705.md) | Annual report, period 2024-12-31 | 0001437749-25-005705 |
| 2025-02-24 | 16:35 ET | [8-K](/filings/0001437749-25-004894.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-004894 |
| 2024-10-24 | 16:51 ET | [10-Q](/filings/0001437749-24-032036.md) | Quarterly report, period 2024-09-30 | 0001437749-24-032036 |
| 2024-10-21 | 16:33 ET | [8-K](/filings/0001437749-24-031651.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-031651 |
| 2024-07-25 | 16:46 ET | [10-Q](/filings/0001437749-24-023484.md) | Quarterly report, period 2024-06-30 | 0001437749-24-023484 |
| 2024-07-22 | 16:32 ET | [8-K](/filings/0001437749-24-023191.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-023191 |
| 2024-06-03 | 16:25 ET | [8-K](/filings/0001437749-24-019035.md) | 5.07 Shareholder vote results | 0001437749-24-019035 |
| 2024-04-25 | 16:13 ET | [10-Q](/filings/0001437749-24-013221.md) | Quarterly report, period 2024-03-31 | 0001437749-24-013221 |
| 2024-04-22 | 16:34 ET | [8-K](/filings/0001437749-24-012710.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-012710 |
| 2024-04-11 | 16:53 ET | [DEF 14A](/filings/0001437749-24-011794.md) | Proxy statement, period 2024-05-30 | 0001437749-24-011794 |
| 2024-02-26 | 16:15 ET | [10-K](/filings/0001437749-24-005530.md) | Annual report, period 2023-12-31 | 0001437749-24-005530 |
| 2024-02-20 | 07:01 ET | [8-K](/filings/0001437749-24-004713.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-004713 |
| 2023-10-26 | 16:14 ET | [10-Q](/filings/0001437749-23-029097.md) | Quarterly report, period 2023-09-30 | 0001437749-23-029097 |
| 2023-10-23 | 16:35 ET | [8-K](/filings/0001437749-23-028766.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-23-028766 |
| 2023-10-23 | 16:32 ET | [8-K](/filings/0001437749-23-028764.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-028764 |
| 2023-10-10 | 16:30 ET | [8-K](/filings/0001437749-23-027976.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001437749-23-027976 |
| 2023-09-13 | 16:30 ET | [8-K](/filings/0001437749-23-025780.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-025780 |
| 2023-07-27 | 16:30 ET | [10-Q](/filings/0001437749-23-020904.md) | Quarterly report, period 2023-06-30 | 0001437749-23-020904 |

Page 1 of 6. [Older](/companies/hstm/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 20:12 ET. No prices; not investment advice.